Comparative study to assess the clinical efficacy of Pippalichitrak ghrita and Shigru kwath in the management of Non-alcoholic fatty liver disease

A comparative study to evaluate the the efficacy of Pippalichitrak ghrita and Shigru kwath in the management of Non alcoholic fatty liver disease (~Yakritodara) - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106367

Enrollment

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Male and female patients aged between 18 and 65 years. 2 Prediagnosed with USG Grade I or Grade II Non-Alcoholic Fatty Liver Disease (NAFLD) and attending the general outpatient department (OPD) of Sanjeevani hospital DSRRAU. 3 Patient willing to sign the consent form for the clinical trial.

Exclusion criteria

Exclusion criteria: 1 Alcohol intake 2 Individuals with a history of cardiovascular disorders 3 Viral hepatitis (HBsAg/anti-HCV positive) 4 Uncontrolled DM (HbA1c greater than 9 percent), CKD, active malignancy. Pregnancy/lactation.

Design outcomes

Primary

Measure	Time frame
To assess the improvement in clinical symptoms and evaluate corresponding supportive changes on ultrasonography findings.Timepoint: 60th day and 75th day	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Savita Dudi

PGIA Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University

drpriyachoudhary06@gmail.com9460670388

Outcome results